Asia Pacific Blood Transfusion Diagnostics Market Size & Outlook
Asia Pacific blood transfusion diagnostics market, 2016-2027 (US$M)
Related Markets
Asia Pacific blood transfusion diagnostics market highlights
- The Asia Pacific blood transfusion diagnostics market generated a revenue of USD 738.0 million in 2020.
- The market is expected to grow at a CAGR of 8% from 2021 to 2027.
- In terms of segment, reagents & kits was the largest revenue generating product in 2020.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2021 to 2027.
Asia Pacific data book summary
| Market revenue in 2020 | USD 738.0 million |
| Market revenue in 2027 | USD 1,260.9 million |
| Growth rate | 8% (CAGR from 2020 to 2027) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data covered | 2016 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Kits, Instruments |
| Key market players worldwide | Grifols SA Ordinary Shares - Class A, Bio-Rad Laboratories Inc, Roche Holding AG ADR, Quotient Sciences, Abbott Laboratories, BioMerieux SA, Siemens Healthineers AG ADR, MedGenome, Beckman Coulter |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.9% of the global blood transfusion diagnostics market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2027.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,260.9 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood Transfusion Diagnostics Market Scope
Blood Transfusion Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific blood transfusion diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to blood transfusion diagnostics market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.17% in 2020. Horizon Databook has segmented the Asia Pacific blood transfusion diagnostics market based on reagents & kits, instruments covering the revenue growth of each sub-segment from 2016 to 2027.
Asia Pacific blood transfusion diagnostics market is expected to grow at the fastest rate during the forecast period. China and Japan, with large geriatric population, are primarily driving the market due to high need for blood transfusion among this group of population.
Increasing awareness about blood donations coupled with launch of various campaigns in India and Australia is further promoting regional growth. However, declining number of blood donors in Singapore and South Korea has led to less adoption of blood transfusion diagnostic tools in Asia Pacific.
Reasons to subscribe to Asia Pacific blood transfusion diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific blood transfusion diagnostics market databook
-
Our clientele includes a mix of blood transfusion diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific blood transfusion diagnostics market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific blood transfusion diagnostics market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific blood transfusion diagnostics market size, by country, 2016-2027 (US$M)
Asia Pacific Blood Transfusion Diagnostics Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
